NAII Overview

Financial Performance: Natural Alternatives International, Inc. reported a net loss of $7.2 million for Q4 FY 2025, compared to a loss of $1.9 million in the same quarter of the previous year, with net sales increasing by 15% to $33.9 million.

Annual Overview: For the fiscal year 2025, the company experienced a net loss of $13.6 million, up from $7.2 million in FY 2024, despite a 14% increase in annual net sales to $129.9 million.

Future Outlook: The company anticipates a net loss in the first half of FY 2026 but expects to achieve profitability in the second half, driven by growth in customer relationships and sales.

Operational Challenges: The net loss was attributed to underutilization of factory capacity, a valuation allowance against deferred tax assets, and litigation settlement costs, despite overall revenue growth.

Partnership Extension: Natural Alternatives International, Inc. has extended its partnership with The Juice Plus+ Company through a new multi-year Manufacturing Agreement for their capsule and powder products sold globally.

Commitment to Quality: Both companies emphasize their long-standing relationship and commitment to delivering high-quality nutritional products backed by scientific research, aiming for mutual benefits from the contract extension.

Financial Performance: Natural Alternatives International, Inc. reported a net loss of $2.2 million for Q3 2025, despite a 14% increase in net sales to $28.8 million compared to the previous year, largely due to increased private-label contract manufacturing sales.

Operational Challenges: The company continues to face operational losses attributed to underutilization of factory capacities, decreased beta-alanine revenue, and rising operating expenses, while maintaining a cautious outlook on profitability for the upcoming fiscal year.

Clinical Trial Results: Natural Alternatives International, Inc. announced that their TriBsyn™ beta-alanine complex significantly increases bioavailability and efficiency while eliminating the common side effect of paresthesia, as published in the journal Food Hydrocolloids for Health.

Product Innovation: TriBsyn™, utilizing proprietary Hydro Oleo technology, offers a higher potency and better absorption of beta-alanine, making it suitable for active aging populations and those seeking enhanced muscle vitality and cognitive performance without discomfort.

New Distribution Partnership: Natural Alternatives International, Inc. has partnered with B&D Nutritional Ingredients to distribute its new carnosine booster, TriBsyn™, targeting the U.S. dietary supplement market.

Product Benefits: TriBsyn™ is designed to enhance beta-alanine absorption without causing the typical paresthesia sensation, aiming to benefit various consumer groups including older adults and those seeking cognitive and physical health support.

Financial Performance: Natural Alternatives International, Inc. reported a net loss of $1.9 million for Q4 2024, with total sales decreasing by 18% to $29.5 million compared to the previous year, leading to an annual net loss of $7.2 million.

Future Outlook: Despite recent losses, the company anticipates improved sales in fiscal 2025, projecting a net loss in the first half but expecting profitability in the second half, bolstered by new business opportunities and product introductions like their TriBsyn™ ingredient.